[1] World Health Organization. Global tuberculosis report 2018.2018 ed. Geneva: World Health Organization, 2018.
[2] Guan X, Benjamin JS, Aaron TF, et al. Pneumonia incidence and mortality in mainland China:Systemic review of Chinese and English literature, 1985-2008. J of Pub Health and Prev Med, 2011; 22, 14-19. http://d.old.wanfangdata.com.cn/OAPaper/oai_pubmedcentral.nih.gov_2909231
[3] Chang TM, Mou CH, Shen TC, et al. Retrospective cohort evaluation on risk of pneumonia in patients with pulmonary tuberculosis. Medicine (Baltimore), 2016; 95, e4000. doi:  10.1097/MD.0000000000004000
[4] Lim HJ, Park JS, Cho YJ, et al. CD4(+)FoxP3(+) T regulatory cells in drug-susceptible and multidrug-resistant tuberculosis. Tuberculosis (Edinb), 2013; 93, 523-8. doi:  10.1016/j.tube.2013.06.001
[5] Heo EY, Chun EJ, Lee CH, et al. Radiographic improvement and its predictors in patients with pulmonary tuberculosis. Int J Infect Dis, 2009; 13, e371-6. doi:  10.1016/j.ijid.2009.01.007
[6] Falzon D, Jaramillo E, Schünemann HJ, et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis:2011 update. Eur Respir J, 2011; 38, 516-28. doi:  10.1183/09031936.00073611
[7] Tierney DB, Franke MF, Becerra MC, et al. Time to culture conversion and regimen composition in multidrug-resistant tuberculosis treatment. PLoS One, 2014; 9, e108035. doi:  10.1371/journal.pone.0108035
[8] Tang S, Tan S, Yao L, et al. Risk factors for poor treatment outcomes in patients with MDR-TB and XDR-TB in China:retrospective multi-center investigation. PLoS One, 2013; 8, e82943. doi:  10.1371/journal.pone.0082943
[9] Kim HR, Hwang SS, Kim HJ, et al. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis. Clin Infect Dis, 2007; 45, 1290-5. doi:  10.1086/522537
[10] Kurbatova EV, Cegielski JP, Lienhardt C, et al. Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis:a secondary analysis of data from two observational cohort studies. Lancet Respir Med, 2015; 3, 201-9. doi:  10.1016/S2213-2600(15)00036-3